A low-intervention prospective-retrospective study to evaluate the pharmacokinetics of elexacaftor/tezacaftor/ivacaftor combination in a Cystic Fibrosis population
Latest Information Update: 15 Oct 2025
At a glance
- Drugs Elexacaftor/ivacaftor/tezacaftor (Primary) ; Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
Most Recent Events
- 15 Oct 2025 New trial record